Cancer-specific innate and adaptive immune rewiring drives resistance to PD-1 blockade in classic Hodgkin lymphoma.
Saved in:
| Title: | Cancer-specific innate and adaptive immune rewiring drives resistance to PD-1 blockade in classic Hodgkin lymphoma. |
|---|---|
| Authors: | Paczkowska J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Tang M; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Astra Zeneca, Waltham, MA, USA., Wright KT; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., Song L; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biomedical Data Science, Dartmouth College, Hanover, NH, USA., Luu K; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; PathAI, Boston, MA, USA., Shanmugam V; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Welsh EL; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Weirather JL; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Besson N; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Olszewski H; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Porter BA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Pfaff KL; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Redd RA; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Cader FZ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; AstraZeneca, City House, Cambridge, UK., Mandato E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Ouyang J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Mechanisms of Cancer Resistance Thematic Center, Bristol Myers Squibb, Cambridge, MA, USA., Calabretta E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Bai G; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA., Lawton LN; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Liu XS; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard T.H. Chan School of Public Health, Boston, MA, USA.; GV20 Therapeutics, LLC, Cambridge, MA, USA., Shipp MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Margaret_Shipp@dfci.harvard.edu. |
| Source: | Nature communications [Nat Commun] 2024 Dec 30; Vol. 15 (1), pp. 10740. Date of Electronic Publication: 2024 Dec 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39737927 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cancer-specific innate and adaptive immune rewiring drives resistance to PD-1 blockade in classic Hodgkin lymphoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Paczkowska+J%22">Paczkowska J</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Tang+M%22">Tang M</searchLink>; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Astra Zeneca, Waltham, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wright+KT%22">Wright KT</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.<br /><searchLink fieldCode="AU" term="%22Song+L%22">Song L</searchLink>; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biomedical Data Science, Dartmouth College, Hanover, NH, USA.<br /><searchLink fieldCode="AU" term="%22Luu+K%22">Luu K</searchLink>; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; PathAI, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Shanmugam+V%22">Shanmugam V</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Welsh+EL%22">Welsh EL</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Weirather+JL%22">Weirather JL</searchLink>; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Besson+N%22">Besson N</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Olszewski+H%22">Olszewski H</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Porter+BA%22">Porter BA</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Pfaff+KL%22">Pfaff KL</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Redd+RA%22">Redd RA</searchLink>; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Cader+FZ%22">Cader FZ</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; AstraZeneca, City House, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Mandato+E%22">Mandato E</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ouyang+J%22">Ouyang J</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Mechanisms of Cancer Resistance Thematic Center, Bristol Myers Squibb, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Calabretta+E%22">Calabretta E</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bai+G%22">Bai G</searchLink>; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lawton+LN%22">Lawton LN</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Armand+P%22">Armand P</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Rodig+SJ%22">Rodig SJ</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Liu+XS%22">Liu XS</searchLink>; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard T.H. Chan School of Public Health, Boston, MA, USA.; GV20 Therapeutics, LLC, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Shipp+MA%22">Shipp MA</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Margaret&#95;Shipp@dfci.harvard.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2024 Dec 30; Vol. 15 (1), pp. 10740. <i>Date of Electronic Publication: </i>2024 Dec 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39737927 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-024-54512-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 10740 Titles: – TitleFull: Cancer-specific innate and adaptive immune rewiring drives resistance to PD-1 blockade in classic Hodgkin lymphoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Paczkowska J – PersonEntity: Name: NameFull: Tang M – PersonEntity: Name: NameFull: Wright KT – PersonEntity: Name: NameFull: Song L – PersonEntity: Name: NameFull: Luu K – PersonEntity: Name: NameFull: Shanmugam V – PersonEntity: Name: NameFull: Welsh EL – PersonEntity: Name: NameFull: Weirather JL – PersonEntity: Name: NameFull: Besson N – PersonEntity: Name: NameFull: Olszewski H – PersonEntity: Name: NameFull: Porter BA – PersonEntity: Name: NameFull: Pfaff KL – PersonEntity: Name: NameFull: Redd RA – PersonEntity: Name: NameFull: Cader FZ – PersonEntity: Name: NameFull: Mandato E – PersonEntity: Name: NameFull: Ouyang J – PersonEntity: Name: NameFull: Calabretta E – PersonEntity: Name: NameFull: Bai G – PersonEntity: Name: NameFull: Lawton LN – PersonEntity: Name: NameFull: Armand P – PersonEntity: Name: NameFull: Rodig SJ – PersonEntity: Name: NameFull: Liu XS – PersonEntity: Name: NameFull: Shipp MA IsPartOfRelationships: – BibEntity: Dates: – D: 30 M: 12 Text: 2024 Dec 30 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 15 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |